scholarly journals Predictors of Recurrence in Hepatitis C Virus Related Hepatocellular Carcinoma after Hepatic Resection: A Retrospective Cohort Study

2014 ◽  
Vol 46 (1) ◽  
pp. 36-41 ◽  
Author(s):  
Ahmed Shehta ◽  
Ayman El Nakeeb ◽  
Hosam Hamed ◽  
Mohamed Abdel Wahab ◽  
Tarek Salah
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cohort Study ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Hepatic Resection ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Predictors Of Recurrence

Incidence rates of hepatitis C virus infection among blood donors in Japan: a nationwide retrospective cohort study

Transfusion ◽  
2018 ◽  
Vol 58 (12) ◽  
pp. 2880-2885 ◽  
Author(s):  
Shigeharu Uchida ◽  
Masahiro Satake ◽  
Akemi Kurisu ◽  
Aya Sugiyama ◽  
Ko Ko ◽  
...  
Keyword(s):  
Cohort Study ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Blood Donors ◽  
Incidence Rates ◽  
Hepatitis C Virus Infection

scholarly journals Risk of rheumatoid arthritis in patients with hepatitis C virus infection receiving interferon-based therapy: a retrospective cohort study using the Taiwanese national claims database

BMJ Open ◽  
2018 ◽  
Vol 8 (7) ◽  
pp. e021747 ◽  
Author(s):  
Chien-Hsueh Tung ◽  
Ning-Sheng Lai ◽  
Chung-Yi Li ◽  
Shiang-Jiun Tsai ◽  
Yen-Chun Chen ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Cohort Study ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Incidence Rate ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Proportional Hazards ◽  
Cox Proportional Hazards ◽  
Hcv Infection

ObjectivesTo illuminate the association between interferon-based therapy (IBT) and the risk of rheumatoid arthritis (RA) in patients infected with hepatitis C virus (HCV).Design, setting, participants and interventionsThis retrospective cohort study used Taiwan’s Longitudinal Health Insurance Database 2005 that included 18 971 patients with HCV infection between 1 January 1997 and 31 December 2012. We identified 1966 patients with HCV infection who received IBT (treated cohort) and used 1:4 propensity score-matching to select 7864 counterpart controls who did not receive IBT (untreated cohort).Outcome measuresAll study participants were followed until the end of 2012 to calculate the incidence rate and risk of incident RA.ResultsDuring the study period, 305 RA events (3.1%) occurred. The incidence rate of RA was significantly lower in the treated cohort than the untreated cohort (4.0 compared with 5.5 per 1000 person-years, p<0.018), and the adjusted HR remained significant at 0.63 (95% CI 0.43 to 0.94, p=0.023) in a Cox proportional hazards regression model. Multivariate stratified analyses revealed that the attenuation in RA risk was greater in men (0.35; 0.15 to 0.81, p=0.014) and men<60 years (0.29; 0.09 to 0.93, p=0.036).ConclusionsThis study demonstrates that IBT may reduce the risk of RA and contributes to growing evidence that HCV infection may lead to development of RA.

Sign in / Sign up

Export Citation Format

Share Document